D
Denali Therapeutics Inc. DNLI
$15.15 $0.261.75%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -191.12% -243.56% -226.90% 62.96% 55.45%
Total Depreciation and Amortization -93.47% -54.13% -54.22% -51.82% 61.09%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -5.60% -36.04% -44.96% -50.84% -36.33%
Change in Net Operating Assets 105.84% 104.14% 91.65% -1,076.91% -1,106.52%
Cash from Operations 2.88% -9.23% -29.56% -78.39% -46.29%
Capital Expenditure -22.98% 16.06% 42.47% 25.79% 27.44%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -127.78% -372.14% -881.99% 0.79% 312.25%
Cash from Investing -135.60% -485.85% -391.09% 4.35% 276.33%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 2,801.92% 65.51% 63.03% 66.18% -94.26%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 2,617.76% 57.68% 63.03% 66.18% -94.26%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 152.67% -294.68% -148.67% 79.68% -20.46%
Weiss Ratings